Xi'an Manareco(SH:688550) 智通财经网·2026-02-13 10:34Core Viewpoint - 瑞联新材 (688550.SH) reported a revenue of 1.677 billion yuan for the year 2025, reflecting a year-on-year growth of 14.95%, and a net profit attributable to shareholders of 311 million yuan, which is a 23.48% increase year-on-year [1] Group 1: Financial Performance - The company achieved a revenue of 1.677 billion yuan in 2025, marking a 14.95% increase compared to the previous year [1] - The net profit attributable to the parent company's shareholders reached 311 million yuan, representing a year-on-year growth of 23.48% [1] Group 2: Business Segments - Revenue growth was primarily driven by the pharmaceutical and electronic materials sectors, with the pharmaceutical segment benefiting from customer inventory adjustments and increased sales of core products [1] - The electronic materials segment experienced growth due to the successful validation of semiconductor photoresist monomer materials and the introduction of certain packaging materials [1] Group 3: Operational Efficiency - The company focused on enhancing operational management efficiency and cost reduction, implementing measures such as cost-saving initiatives and lean processes to improve the management system [1] - Strengthening the coordination between research, production, supply, and sales helped to lower production costs and enhance profitability [1]